Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devanjan Sikder

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Depletion of high-content CD14<sup>+</sup> cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturingXiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, et al.
Transplantation and Cellular Therapy|February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory HurdlesKedar Kirtane, Michael Kalos, Rocky Billups, et al.
Cancer Discovery|July 16, 2021
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent PembrolizumabPrasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, et al.
The New England Journal of Medicine|September 28, 2022
GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Depletion of high-content CD14<sup>+</sup> cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturingXiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, et al.
Transplantation and Cellular Therapy|February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory HurdlesKedar Kirtane, Michael Kalos, Rocky Billups, et al.
Cancer Discovery|July 16, 2021
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent PembrolizumabPrasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, et al.
The New England Journal of Medicine|September 28, 2022
GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Pageof 3